Merck KGaA (FRA:MRKC)

Germany flag Germany · Delayed Price · Currency is EUR
24.00
+0.20 (0.84%)
At close: Dec 5, 2025
-14.89%
Market Cap 52.46B
Revenue (ttm) 21.27B
Net Income (ttm) 2.96B
Shares Out n/a
EPS (ttm) 6.80
PE Ratio 17.75
Forward PE 14.42
Dividend 0.30 (1.28%)
Ex-Dividend Date Apr 29, 2025
Volume 29
Average Volume 3
Open 23.60
Previous Close 23.80
Day's Range 23.60 - 24.00
52-Week Range 20.40 - 30.60
Beta n/a
RSI 65.31
Earnings Date Mar 5, 2026

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables, devices, instruments, software, and services for research, production, and testing; process solutions consisting of filtration devices, chromatography... [Read more]

Industry Pharmaceutical Preparations
Founded 1668
Employees 59,020
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol MRKC
Full Company Profile

Financial Performance

In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.

Financial Statements

News

There is no news available yet.